Efficacy and safety of low-dose ganciclovir preemptive therapy in allogeneic haematopoietic stem cell transplant recipients compared with conventional-dose ganciclovir: a prospective observational study.

Abstract

OBJECTIVES We performed a prospective observational study comparing the efficacy and safety of low-dose ganciclovir (5 mg/kg/day) as initial preemptive therapy in allogeneic haematopoietic stem cell transplantation (HSCT) recipients with conventional-dose ganciclovir (10 mg/kg/day). METHODS All adult patients undergoing allogeneic HSCT were enrolled at a… (More)
DOI: 10.1093/jac/dks043

4 Figures and Tables

Topics

  • Presentations referencing similar topics